Notable
Futibatinib in Combination With Durvalumab Prior to Cystectomy · Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Primary and study completion pushed from Dec 31, 2026 to Jul 31, 2027
Yuanquan YangPhase 2 NCT06263153 Registry history of NCT06263153 on ClinicalTrials.gov (opens the registry)